← 홈

전체 프로그램

ADC 1032 · Antibody 4683 · CGT 2713 · 다음 갱신 D-6 · 마지막 7월 21일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 3,526개
CGTBiologicstaleShanghai AbelZeta Ltd.Phase 1

C-CAR011 (C-CAR011)

Refractory or Relapsed B-cell Non-Hodgkin Lymphoma · FRα

#FR#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 6상태 ACTIVE
CGTBiologicstaleShanghai AbelZeta Ltd.Phase 1

C-CAR088 (C-CAR088)

Multiple Myeloma · Multiple Myeloma

#MultipleMyeloma#CGT#Phase1#세포유전치료#CAR-T+2
임상시험 6상태 ACTIVE
CGTBiologicstaleCabaletta BioPhase 2

CABA-201 (CABA-201)

Relapsing Multiple Sclerosis (RMS); Progressive Multiple Sclerosis (PMS) · Pemphigus Vulgaris

#PemphigusVulgaris#CGT#Phase2#세포유전치료#CAR-T+5
임상시험 6상태 RECRUITING
CGTBiologicstaleCity of Hope Medical CenterPhase 1

CD19CAR-CD28-CD3zeta-EGFRt-expressing Tn/mem T-lymphocytes (CD19CAR-CD28-CD3zeta-EGFRt-expressing Tn/mem T-lymphocytes)

Central Nervous System Lymphoma · EGFR

#EGFR#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 6상태 RECRUITING
CGTBiologicstaleCity of Hope Medical CenterPhase 1

CD19CAR-CD28-CD3zeta-EGFRt-expressing Tn/mem-enriched T-lymphocytes (CD19CAR-CD28-CD3zeta-EGFRt-expressing Tn/mem-enriched T-lymphocytes)

B Acute Lymphoblastic Leukemia; Recurrent Acute Lymphoblastic Leukemia · EGFR

#EGFR#CGT#Phase1#세포유전치료#CAR-T+4
임상시험 6상태 RECRUITING
AntibodystaleMerckPhase 2

pembrolizumab (Keytruda, Coformulated favezelimab/pembrolizumab)

Metastatic Urothelial Carcinoma; Urothelial Neoplasms · Metastatic Urothelial Carcinoma

#MetastaticUrothelialCarcinoma#Antibody#Phase2#항체#면역항체+3
효능 ORR 6.8%임상시험 6상태 RECRUITING
ADCBiologicstaleDaiichi SankyoPhase 1

DS-6000a (DS-6000a)

Renal Cell Carcinoma; Ovarian Tumor · Renal Cell Carcinoma

#RenalCellCarcinoma#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2
임상시험 6상태 RECRUITING
ADCBiologicstaleRemeGenPhase 2

disitamab vedotin (Disitamab Vedotin, RC48, Disitamab Vedotin Plus Cadonilimab)

Bile Duct Adenocarcinoma Non-Resectable; HER2 Gene Mutation · HER2

#HER2#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3
임상시험 6상태 ACTIVE
ADCBiologicstaleRemeGenApproved

disitamab vedotin (Disitamab Vedotin, RC48, Disitamab Vedotin and Gemcitabine)

Radical Cystectomy; Urothelial Carcinoma · Radical Cystectomy

#RadicalCystectomy#ADC#Approved#항체약물접합체#antibody-drug-conjugate+2
임상시험 6상태 ACTIVE
ADCBiologicstaleImmunoGen, Inc.Phase 1

IMGN901 (IMGN901)

Multiple Myeloma · Multiple Myeloma

#MultipleMyeloma#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+1
효능 ORR 0.00%임상시험 6상태 ACTIVE
CGTBiologicstaleNational Institutes of Health C…Phase 2

Individual Patient TCR Transduced PBL (Individual Patient TCR Transduced PBL)

Metastatic HPV-16 Positive Squamous Cell Anal Cancer · Multi-target

#Multi-target#CGT#Phase2#세포유전치료#CAR-T+3
임상시험 6상태 DISCONTINUED
AntibodystaleKite, A Gilead CompanyPhase 1

Lenzilumab (Lenzilumab)

Relapsed/Refractory Large B-cell Lymphoma · FRα

#FR#Antibody#Phase1#항체#면역항체+4
효능 ORR 9.9%임상시험 6상태 DISCONTINUED
ADCBiologicstaleAbbViePhase 3

Mirvetuximab soravtansine plus Bevacizumab (Mirvetuximab soravtansine plus Bevacizumab)

Ovarian Cancer; Peritoneal Cancer · Ovarian Cancer

#OvarianCancer#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+2
효능 ORR 100%임상시험 6상태 RECRUITING
ADCBiologicstaleGlaxoSmithKlinerezetecanPhase 3

Mocertatug rezetecan (Mocertatug rezetecan)

Ovarian Neoplasms · Ovarian Neoplasms

#OvarianNeoplasms#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+3
임상시험 6상태 RECRUITING
ADCBiologicstaleBase Therapeutics (Shanghai) Co…Phase 2

NK510 (NK510)

NSCLC · Rare Malignant Neoplasm

#RareMalignantNeoplasm#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 6상태 RECRUITING
ADCBiologicstaleMing-Yuan ChenPhase 3

Neoadjuvant and Adjuvant Becotatug Vedotin (Neoadjuvant and Adjuvant Becotatug Vedotin)

Locally Advanced Head and Neck Squamous Cell Carcinoma · Locally Advanced Head and Neck Squamous

#LocallyAdvancedHeadandNeckSquamo#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+1
임상시험 6상태 RECRUITING
ADCBiologicstaleSenhwa Biosciences, Inc.Phase 1

Pidnarulex (Pidnarulex)

Anatomic Stage III Breast Cancer AJCC v8; Anatomic Stage IV Breast Cancer AJCC v8 · HER2

#HER2#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+3
임상시험 6상태 RECRUITING
ADCBiologicstaleSorrento Therapeutics, Inc.Phase 2

STI-6129 (STI-6129)

Advanced Solid Tumor · Light Chain (AL) Amyloidosis

#LightChainALAmyloidosis#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 6상태 ACTIVE
ADCBiologicstaleTasly Pharmaceutical Group Co.,…Phase 2

STRO-002 (STRO-002)

Neoplasm Malignant · Ovarian Cancer

#OvarianCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 6상태 DISCONTINUED
ADCBiologicstaleAstraZenecasPhase 3

Sonesitatug vedotin (Sonesitatug vedotin)

Gastric Cancer; Gastroesophageal Junction Adenocarcinoma · Gastric Cancer

#GastricCancer#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+3
임상시험 6상태 RECRUITING

48 / 177 페이지

← 이전다음 →